Semler Scientific Inc. (SMLR) News
Filter SMLR News Items
SMLR News Results
|Event/Time||Symbol||Company||News Detail||Start||End||Change||POWR Rating|
|Loading, please wait...|
Latest SMLR News From Around the Web
Below are the latest news stories about Semler Scientific Inc that investors may wish to consider to help them evaluate SMLR as an investment opportunity.
There’s a lot to like about investing in the healthcare sector, so get to know three stocks that make great investments right now.
Semler Scientific (SMLR) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Novocure is on a mission to give people with cancer a fighting chance. The company is commercializing a brand-new modality of cancer treatment, called tumor treating fields (TTFields). This idea sounded radical when it was first introduced, but Novocure has won over its critics.
Editor's note: Seeking Alpha is proud to welcome Growth Hunter as a new contributor. It's easy to become a Seeking Alpha contributor and earn money for your best investment ideas. Active contributors also get free access to SA PREMIUM. Click here to find out more »Investment Overview Semler Scientific (SMLR)...
Semler Scientific (SMLR) was on a tear with a simple device and a smart business model generating tremendous margins and cash flow, but this got interrupted by the pandemic. We think this is temporary, and the company is well positioned to weather the storm. The company has developed a simple...
This article was written by David Zanoni in collaboration with Risk Research Inc. It is rare to find a company with ten years of above-average revenue growth, four years of operating cash flow growth and zero debt. Bought right, these stocks have the potential for major investment returns. Risk Research...
Q1 2020 Semler Scientific Inc Earnings Call
Bet on five top-ranked stocks with higher ROE derived the DuPont way.
Semler Scientific, Inc. (OTCQB: SMLR), a company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers, today reported financial results for the three months ended March 31, 2020.
Semler Scientific, Inc. (OTCQB: SMLR), a company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers, today announced that it will report financial results for the first quarter ended March 31, 2020 after the close of U.S. financial markets on Monday, May 4, 2020. Doug Murphy-Chutorian, M.D., chief executive officer of Semler Scientific, will host a conference call at 4:30 pm ET the same day. Andrew Weinstein, senior vice president, finance and accounting, and Dennis Rosenberg, chief marketing officer, will join him on the call.